These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1672154)

  • 1. Expression of c-erbB-2 oncoprotein in salivary gland tumours: an immunohistochemical study.
    Kernohan NM; Blessing K; King G; Corbett IP; Miller ID
    J Pathol; 1991 Jan; 163(1):77-80. PubMed ID: 1672154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness.
    Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I
    Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-kit expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and monomorphic adenoma.
    Edwards PC; Bhuiya T; Kelsch RD
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 May; 95(5):586-93. PubMed ID: 12738950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
    Edwards PC; Bhuiya T; Kelsch RD
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical detection of E-cadherin in certain types of salivary gland tumours.
    Andreadis D; Epivatianos A; Mireas G; Nomikos A; Poulopoulos A; Yiotakis J; Barbatis C
    J Laryngol Otol; 2006 Apr; 120(4):298-304. PubMed ID: 16623973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of C-KIT (CD117) molecule in benign and malignant salivary gland tumours.
    Andreadis D; Epivatianos A; Poulopoulos A; Nomikos A; Papazoglou G; Antoniades D; Barbatis C
    Oral Oncol; 2006 Jan; 42(1):57-65. PubMed ID: 16140564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of C-erbB-2 oncogene mRNA in salivary gland tumors].
    Sun H; Wu S; Ouyang J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1999 Sep; 34(5):289-91. PubMed ID: 11776895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell proliferation correlates with prognosis in acinic cell carcinomas of salivary gland origin. Immunohistochemical study of 30 cases using the MIB 1 antibody in formalin-fixed paraffin sections.
    Skalova A; Leivo I; Von Boguslawsky K; Saksela E
    J Pathol; 1994 May; 173(1):13-21. PubMed ID: 7931834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor immunoexpression evaluation in malignant salivary gland tumours.
    Monteiro LS; Bento MJ; Palmeira C; Lopes C
    J Oral Pathol Med; 2009 Jul; 38(6):508-13. PubMed ID: 19317849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-erbB-2 protein and neuroendocrine expression in breast carcinomas.
    Nesland JM; Ottestad L; Heikilla R; Holm R; Tveit K; Børresen AL
    Anticancer Res; 1991; 11(1):161-7. PubMed ID: 1673329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PCNA, Ki-67 and p53 expressions in submandibular salivary gland tumours.
    Alves FA; Pires FR; De Almeida OP; Lopes MA; Kowalski LP
    Int J Oral Maxillofac Surg; 2004 Sep; 33(6):593-7. PubMed ID: 15308260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-erbB-2 oncogene expression in salivary gland tumours.
    Kärjä V; Syrjänen S; Kataja V; Syrjänen K
    ORL J Otorhinolaryngol Relat Spec; 1994; 56(4):206-12. PubMed ID: 7915830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours.
    Vargas PA; Cheng Y; Barrett AW; Craig GT; Speight PM
    J Oral Pathol Med; 2008 May; 37(5):309-18. PubMed ID: 18248354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.
    Clauditz TS; Reiff M; Gravert L; Gnoss A; Tsourlakis MC; Münscher A; Sauter G; Bokemeyer C; Knecht R; Wilczak W
    Pathology; 2011 Aug; 43(5):459-64. PubMed ID: 21670724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CK7+/CK20- immunoexpression profile is typical of salivary gland neoplasia.
    Meer S; Altini M
    Histopathology; 2007 Jul; 51(1):26-32. PubMed ID: 17593078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunophenotypical profiles of salivary gland tumours: a new evidence for their histogenetic origin.
    Gürbüz Y; Yildiz K; Aydin O; Almaç A
    Pathologica; 2006 Apr; 98(2):147-52. PubMed ID: 16929788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT3 expression in salivary gland tumours.
    de Araújo VC; Furuse C; Cury PR; Altemani A; de Araújo NS
    Oral Oncol; 2008 May; 44(5):439-45. PubMed ID: 17826306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-erbB-2 expression in squamous cell carcinoma of the head and neck.
    Field JK; Spandidos DA; Yiagnisis M; Gosney JR; Papadimitriou K; Stell PM
    Anticancer Res; 1992; 12(3):613-9. PubMed ID: 1377893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer.
    McCann AH; Dervan PA; O'Regan M; Codd MB; Gullick WJ; Tobin BM; Carney DN
    Cancer Res; 1991 Jun; 51(12):3296-303. PubMed ID: 1674898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between c-erbB-2 oncoprotein expression and prognosis in salivary gland malignant pleomorphic adenoma].
    Yan Y; Guo Q; Nan P
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1995 Nov; 30(6):326-8, 383. PubMed ID: 8762532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.